Junling Kang

Junling Kang

Auto-generated profile, based on publicly available information

Junling Kang

Department of Neurology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
WQWenhao Qi
Wenhao Qi
XZXiaohong Zhu
Xiaohong Zhu
DHDanni He
Danni He
BWBin Wang
Bin Wang
SCShihua Cao
Shihua Cao
JKJunling Kang
Junling Kang
Background: With the rise of artificial intelligence (AI) in the field of dementia biomarker research, exploring its current developmental trends and research focuses has become increasingly important. This study, using literature data mining, analyzes and assesses the key contributions and development scale of AI in dementia biomarker research. Objective: The aim of this study was to comprehensively evaluate the current state, hot topics, and future trends of AI in dementia biomarker research globally. Methods: This study thoroughly analyzed the literature in the application of AI to dementia biomarkers across various dimensions, such as publication volume, authors, institutions, journals, and countries, based on the Web of Science Core Collection. In addition, scales, trends, and potential connections between AI and biomarkers were extracted and deeply analyzed through multiple expert panels. Results: To date, the field includes 1070 publications across 362 journals, involving 74 countries and 1793 major research institutions, with a total of 6455 researchers. Notably, 69.41% (994/1432) of the researchers ceased their studies before 2019. The most prevalent algorithms used are support vector machines, random forests, and neural networks. Current research frequently focuses on biomarkers such as imaging biomarkers, cerebrospinal fluid biomarkers, genetic biomarkers, and blood biomarkers. Recent advances have highlighted significant discoveries in biomarkers related to imaging, genetics, and blood, with growth in studies on digital and ophthalmic biomarkers. Conclusions: The field is currently in a phase of stable development, receiving widespread attention from numerous countries, institutions, and researchers worldwide. Despite this, stable clusters of collaborative research have yet to be established, and there is a pressing need to enhance interdisciplinary collaboration. Algorithm development has shown prominence, especially the application of support vector machines and neural networks in imaging studies. Looking forward, newly discovered biomarkers are expected to undergo further validation, and new types, such as digital biomarkers, will garner increased research interest and attention.

20 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
WQWenhao Qi
Wenhao Qi
SSShiying Shen
Shiying Shen
CDChaoqun Dong
Chaoqun Dong
MZMengjiao Zhao
Mengjiao Zhao
SZShuaiqi Zang
Shuaiqi Zang
SCShihua Cao
Shihua Cao
Background: With the rapid development of digital biomarkers in Parkinson disease (PD) research, it has become increasingly important to explore the current research trends and key areas of focus. Objective: This study aimed to comprehensively evaluate the current status, hot spots, and future trends of global PD biomarker research, and provide a systematic review of deep learning models for freezing of gait (FOG) digital biomarkers. Methods: This study used bibliometric analysis based on the Web of Science Core Collection database to conduct a comprehensive analysis of the multidimensional landscape of Parkinson digital biomarkers. After identifying research hot spots, the study also followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines for a scoping review of deep learning models for FOG from 5 databases: Web of Science, PubMed, IEEE Xplore, Embase, and Google Scholar. Results: A total of 750 studies were included in the bibliometric analysis, and 40 studies were included in the scoping review. The analysis revealed a growing number of related publications, with 3700 researchers contributing. Neurology had the highest average annual participation rate (12.46/19, 66%). The United States contributed the most research (192/1171, 16.4%), with 210 participating institutions, which was the highest among all countries. In the study of deep learning models for FOG, the average accuracy of the models was 0.92, sensitivity was 0.88, specificity was 0.90, and area under the curve was 0.91. In addition, 31 (78%) studies indicated that the best models were primarily convolutional neural networks or convolutional neural networks–based architectures. Conclusions: Research on digital biomarkers for PD is currently at a stable stage of development, with widespread global interest from countries, institutions, and researchers. However, challenges remain, including insufficient interdisciplinary and interinstitutional collaboration, as well as a lack of corporate funding for related projects. Current research trends primarily focus on motor-related studies, particularly FOG monitoring. However, deep learning models for FOG still lack external validation and standardized performance reporting. Future research will likely progress toward deeper applications of artificial intelligence, enhanced interinstitutional collaboration, comprehensive analysis of different data types, and the exploration of digital biomarkers for a broader range of Parkinson symptoms. Trial Registration: Open Science Foundation (OSF Registries) OSF.IO/RG8Y3; https://doi.org/10.17605/OSF.IO/RG8Y3

27 February 2024 in JMIR Preprints
Verified
Preprint
Open access
WQWenhao Qi
Wenhao Qi
XZXiaohong Zhu
Xiaohong Zhu
DHDanni He
Danni He
BWBin Wang
Bin Wang
SCShihua Cao
Shihua Cao
JKJunling Kang
Junling Kang
BACKGROUND With the rise of artificial intelligence (AI) in the field of dementia biomarker research, exploring its current developmental trends and research focuses has become increasingly important. This study, using literature data mining, analyzes and assesses the key contributions and development scale of AI in dementia biomarker research. OBJECTIVE The aim of this study was to comprehensively evaluate the current state, hot topics, and future trends of AI in dementia biomarker research globally. METHODS This study thoroughly analyzed the literature in the application of AI to dementia biomarkers across various dimensions, such as publication volume, authors, institutions, journals, and countries, based on the Web of Science Core Collection. In addition, scales, trends, and potential connections between AI and biomarkers were extracted and deeply analyzed through multiple expert panels. RESULTS To date, the field includes 1070 publications across 362 journals, involving 74 countries and 1793 major research institutions, with a total of 6455 researchers. Notably, 69.41% (994/1432) of the researchers ceased their studies before 2019. The most prevalent algorithms used are support vector machines, random forests, and neural networks. Current research frequently focuses on biomarkers such as imaging biomarkers, cerebrospinal fluid biomarkers, genetic biomarkers, and blood biomarkers. Recent advances have highlighted significant discoveries in biomarkers related to imaging, genetics, and blood, with growth in studies on digital and ophthalmic biomarkers. CONCLUSIONS The field is currently in a phase of stable development, receiving widespread attention from numerous countries, institutions, and researchers worldwide. Despite this, stable clusters of collaborative research have yet to be established, and there is a pressing need to enhance interdisciplinary collaboration. Algorithm development has shown prominence, especially the application of support vector machines and neural networks in imaging studies. Looking forward, newly discovered biomarkers are expected to undergo further validation, and new types, such as digital biomarkers, will garner increased research interest and attention.

21 January 2025 in JMIR Preprints
Verified
Preprint
Open access
WQWenhao Qi
Wenhao Qi
SSShiying Shen
Shiying Shen
CDChaoqun Dong
Chaoqun Dong
MZMengjiao Zhao
Mengjiao Zhao
SZShuaiqi Zang
Shuaiqi Zang
SCShihua Cao
Shihua Cao
BACKGROUND With the rapid development of digital biomarkers in Parkinson disease (PD) research, it has become increasingly important to explore the current research trends and key areas of focus. OBJECTIVE This study aimed to comprehensively evaluate the current status, hot spots, and future trends of global PD biomarker research, and provide a systematic review of deep learning models for freezing of gait (FOG) digital biomarkers. METHODS This study used bibliometric analysis based on the Web of Science Core Collection database to conduct a comprehensive analysis of the multidimensional landscape of Parkinson digital biomarkers. After identifying research hot spots, the study also followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines for a scoping review of deep learning models for FOG from 5 databases: Web of Science, PubMed, IEEE Xplore, Embase, and Google Scholar. RESULTS A total of 750 studies were included in the bibliometric analysis, and 40 studies were included in the scoping review. The analysis revealed a growing number of related publications, with 3700 researchers contributing. Neurology had the highest average annual participation rate (12.46/19, 66%). The United States contributed the most research (192/1171, 16.4%), with 210 participating institutions, which was the highest among all countries. In the study of deep learning models for FOG, the average accuracy of the models was 0.92, sensitivity was 0.88, specificity was 0.90, and area under the curve was 0.91. In addition, 31 (78%) studies indicated that the best models were primarily convolutional neural networks or convolutional neural networks–based architectures. CONCLUSIONS Research on digital biomarkers for PD is currently at a stable stage of development, with widespread global interest from countries, institutions, and researchers. However, challenges remain, including insufficient interdisciplinary and interinstitutional collaboration, as well as a lack of corporate funding for related projects. Current research trends primarily focus on motor-related studies, particularly FOG monitoring. However, deep learning models for FOG still lack external validation and standardized performance reporting. Future research will likely progress toward deeper applications of artificial intelligence, enhanced interinstitutional collaboration, comprehensive analysis of different data types, and the exploration of digital biomarkers for a broader range of Parkinson symptoms. CLINICALTRIAL Open Science Foundation (OSF Registries) OSF.IO/RG8Y3; https://doi.org/10.17605/OSF.IO/RG8Y3